HIV Medicine

Article	Citations
	99
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	84
Issue Information	84
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	77
	51
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	50
	48
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	40
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	39
Issue Information	37
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	33
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	32
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	31
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	30
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	29
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	29
Reflections on a specialist HIV menopause service	27
Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta‐analysis	26
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	25
HIV cure: Are we going to make history?	21
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study	20
	20
Issue Information	19
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	19
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	19

Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	19
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	19
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	17
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	16
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	16
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	16
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	15
Using an automated decision support tool to improve HIV prescribing: A feasibility study	14
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	14
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	14
Influence of physical activity on endothelial function in people living with HIV	14
Issue Information	14
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	14
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	14
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	14
Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV at the Southern Alberta Clinic since 1985	14
Issue Information	14
The value of herpes zoster prevention in people aging with HIV: A narrative review	14
Special issue on Women and HIV to mark International Women’s Day	13
	13
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	13
Microbial translocation is associated with advanced liver fibrosis among people with HIV	13
	13
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature	13
Issue Information	13
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	13
	13
Issue Information	13
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	12
AI in medicine: No longer the future, but the present	12
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	12
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	12
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual	12
	11
Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study	11
Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY	11
Gender equality in leadership of HIV care cascade clinical trials: A methodological study	11
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	10
	10
Oral Abstracts	10
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	10
	10
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection	10
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	10
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	10
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
Late diagnosis of human immunodeficiency virus (HIV) and its associated factors in Asian countries: A systematic review	9
Issue Information	9
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	9
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	9

Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	9
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	9
Author Index	9
Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia	9
The role of HIV as a risk modifier for coronary endothelial function in young adults	9
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection	9
Issue Information	9
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	9
Author Index	9
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	8
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	8
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary HIV care centre in Gaborone, Botswana: A cross‐s	8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev	8
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	8
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	8
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	8
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	8
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	8
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	8
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV	8
Anticholinergic medications associated with falls and frailty in people with HIV	8
Immune response to ART initiation in advanced HIV infection	7
Managing cardiovascular risk in people living with HIV in Asia – where are we now?	7
Late diagnosis of HIV: An updated consensus definition	7
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	7
Issue Information	7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021	7
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)	7
Issue Information	7
	7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV	7
Issue Information	7
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	7
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	6
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	6
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	6
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	6
	6
Issue Information	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	6
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	6
CROI 2024 BHIVA working group summary	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Issue Information	6
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	6
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	6
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	6
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	6
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	6
	6
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
British HIV Association guidelines for the management of HIV‐2 2021	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Issue Information	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	5
	5
	5
No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults	5
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
	5
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation	5
Issue Information	5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	5
	5

	5
Erratum	5
Issue Information	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’	5
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	5
Cardiac adiposity as a modulator of cardiovascular disease in HIV	5
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	5
	5
Issue Information	5
Natural occurrence of drug resistance mutations to the HIV‐1 capsid inhibitor lenacapavir	5
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	5
Long‐term outcomes for children and adolescents with Kaposi sarcoma	5
Abstracts	5
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria	4
	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia	4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	4
Issue Information	4
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia	4
	4
The spectrum of kidney biopsy findings in Chinese HIV‐infected patients	4
PrEP for women in Europe: a systematic literature review	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
HIV and fracture: Risk, assessment and intervention	4
	4
	4
Failure to return pillbox is a predictor of being lost to follow‐up among people living with HIV on antiretroviral therapy in rural Tanzania	4
People with HIV have a higher risk of COVID‐19 diagnosis but similar outcomes to the general population	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021	4
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat	4
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach	4
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study	4
	4
Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
Issue Information	4
Collection of menopause data in studies of women living with HIV: A systematic literature review	4
Issue Information	4
People diagnosed with HIV before continuing care in England are extremely unlikely to pass on HIV in England	4
Late diagnosis of HIV in 2022: Why so little change?	4
Advanced HIV disease: A review of diagnostic and prophylactic strategies	4
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors	4